|
table 4
Transjugular Intrahepatic Portosystemic Shunt Versus
Endoscopic Sclerotherapy for the Prevention of Variceal Bleeding in
Cirrhosis: A Randomized Multicenter Trial
|
table 4.
Encephalopathy
|
|
| Encephalopathy |
|
Sclerotherapy |
TIPS |
|
| Total |
N° patients (N°
episodes) |
10 (12)* |
21 (39) |
| First 6 months |
N° patients (N°
episodes) |
6 (6) |
16 (31) |
| After 6 months |
N° patients (N°
episodes) |
6 (6) |
6 (8) |
| Grade I-II |
N° episodes |
10 |
31 |
| Grade III-IV |
N° episodes |
3 |
8 |
| Hospitalized |
N° patients (N°
episodes) |
4 (4) |
7 (10) |
|
* In this group,
two patients underwent TIPS because of rebleeding, and developed
3 episodes of encephalopathy included in the total count. One
patient underwent surgical porta-caval anastomosis because of
rebleeding and developed an unknown number of episodes of hepatic
encephalopathy (only one included in the total count).
.gif) In this
group, one patient developed chronic recurrent encephalopathy and
died after 6 months. Another patient was treated with surgical
porta-caval anastomosis because of TIPS failure, and experienced
multiple episodes of encephalopathy immediately thereafter (the
exact number is unknown, and only one episode is included in the
total count). The patient eventually improved and was alive and
well at the end of follow-up. |
|
Return To
Article
table Of Contents
|
